Atlas Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5K | Hold |
|
|||||
|
2025
Q1 | $18.6K | Sell |
|
|||||
|
2024
Q4 | $514K | Sell |
|
|||||
|
2024
Q3 | $767K | Sell |
|
|||||
|
2024
Q2 | $929K | Sell |
|
|||||
|
2024
Q1 | $1.05M | Sell |
|
|||||
|
2023
Q4 | $951K | Buy |
|
|||||
|
2023
Q3 | $756K | Sell |
|
|||||
|
2023
Q2 | $689K | Hold |
|
|||||
|
2023
Q1 | $677K | Sell |
|
|||||
|
2022
Q4 | $580K | Sell |
|
|||||
|
2022
Q3 | $653K | Sell |
|
|||||
|
2022
Q2 | $785K | Sell |
|
|||||
|
2022
Q1 | $863K | Buy |
|
|||||
|
2021
Q4 | $849K | Buy |
|
|||||
|
2021
Q3 | $510K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $277K | Sell |
|
|||||
|
2018
Q2 | $519K | Sell |
|
|||||
|
2018
Q1 | $1.17M | Buy |
|